Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL464P (RNA, 7SL, cytoplasmic 464, pseudogene) is a human non-coding pseudogene belonging to a large family of 7SL RNA-derived pseudogenes. The majority of these sequences in the genome are non-functional remnants thought to arise from reverse transcription of 7SL RNA, resulting in sequence copies that do not produce functional RNAs or proteins[6][3][7][5]. No evidence exists that RN7SL464P has biological activity, participates in disease, or can be targeted therapeutically. It is not known to interact with drugs, participate in signaling, or serve as a biomarker. Pseudogenes like RN7SL464P sometimes complicate genetic assays due to sequence similarity with corresponding functional genes, but do not themselves encode active molecules[6][3][4][10].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 464, pseudogene (RN7SL464P).